Skip to main content
. 2020 Jul 20;12(7):682. doi: 10.3390/pharmaceutics12070682

Table 2.

The particle size, zeta potential, PDI and entrapment efficacy of the NLC compositions (mean and ± SD).

After 1 Day After 1 Week
Zave (d.nm) PDI ZP (mV) EE% Zave (d.nm) PDI ZP (mV)
NLC1 202.33 ± 0.70 0.42 ± 0.008 −10.0 ± 0.3 83.50 285.67 ± 4.06 0.55 ± 0.01 −10.0 ± 0.3
NLC2 192.17 ± 2.86 0.30 ± 0.040 −11.9 ± 0.4 83.47 241.13 ± 1.80 0.46 ± 0.02 −9.2 ± 0.2
NLC3 128.87 ± 3.96 0.35 ± 0.015 −3.7 ± 0.2 95.07 141.07 ± 1.86 0.46 ± 0.02 −13.3 ± 0.3
NLC4 96.46 ± 0.63 0.20 ± 0.006 −3.3 ± 0.4 91.06 122.50 ± 0.50 0.43 ± 0.01 −4.9 ± 0.6
NLC5 188.27 ± 2.70 0.29 ± 0.006 −10.2 ± 0.1 86.19 264.77 ± 7.21 0.49 ± 0.02 −9.4 ± 0.2
NLC6 200.70 ± 7.63 0.34 ± 0.039 −7.4 ± 0.1 86.94 270.07 ± 6.66 0.49 ± 0.03 −15.8 ± 0.6
NLC7 113.13 ± 0.81 0.25 ± 0.005 −8.6 ± 0.2 91.78 143.63 ± 3.97 0.44 ± 0.04 −9.5 ± 0.6
NLC8 103.83 ± 0.46 0.23 ± 0.006 −6.2 ± 0.2 91.02 137.83 ± 0.38 0.45 ± 0.01 −7.7 ± 0.2